Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.7400 (-0.1%) ($19.2500 - $19.9500) on Fri. Jul. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 32 | Latest Price | $19.7400(-0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.01% in a week (0% probabilities). VIXM(-35%) VXX(-34%) TLT(-12%) UNG(-6%) IFRA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
1 - 5 Day Possible Target | $10.28(-47.92%) | Resistance Level | $20.94 | 5 Day Moving Average | $19.83(-0.45%) | 10 Day Moving Average | $20.01(-1.35%) | 20 Day Moving Average | $20.94(-5.73%) | To recent high | -50.6% | To recent low | 3.6% | Market Cap | $1.467b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |